AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9757191 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery following induction chemo-radiotherapy in locally advanced NSCLC
Number of subjects: 0
Study 9757191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer chemotherapy for advanced NSCLC
Number of subjects: 0
Study 9757191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer chemotherapy in metastatic NSCLC
Number of subjects: 0
Study 9757191 — intervention group
Group type: EXPERIMENTAL
Intervention: New agents (irinotecan, paclitaxel, docetaxel, vinorelbine, gemcitabine) along with combination chemotherapy
Number of subjects: 0
Study 8058236 — intervention group
Group type: EXPERIMENTAL
Intervention: Terodiline, 25 mg twice daily
Number of subjects: 93
Study 8058236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 3132181 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprostil 70 micrograms bid
Number of subjects: 72
Study 3132181 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprostil 35 micrograms bid
Number of subjects: 72
Study 3132181 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprostil 7 micrograms bid
Number of subjects: 72
Study 3132181 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprostil 70 micrograms/d
Number of subjects: 72
Study 3132181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 31583943 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF support during EC and docetaxel
Number of subjects: 0
Study 31583943 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy without G‐CSF support
Number of subjects: 0
Study 31583943 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF use
Number of subjects: 0
Study 30526016 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-assisted exercise group
Number of subjects: 84
Study 30526016 — intervention group
Group type: COMPARATOR
Intervention: Conventional self-exercise group
Number of subjects: 84
Study 28578799 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-bearing TAA through anterior approach
Number of subjects: 217
Study 28578799 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-bearing TAA through lateral approach
Number of subjects: 217
Study 28578799 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-arthritic tibiotalar joint)
Number of subjects: 217
Study 26503276 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated curtains for dengue prevention
Number of subjects: 1333
Study 23651146 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory rehabilitation intervention groups
Number of subjects: 31
Study 23651146 — intervention group
Group type: COMPARATOR
Intervention: Self-help control group
Number of subjects: 31
Study 21293252 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-monitored patients
Number of subjects: 1473
Study 21293252 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative duration of BIS values less than 45
Number of subjects: 1473
Study 19623435 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (5HT2a/c antagonist)
Number of subjects: 20
Study 19623435 — intervention group
Group type: COMPARATOR
Intervention: Control group (no trazodone)
Number of subjects: 20
Study 16510641 — intervention group
Group type: EXPERIMENTAL
Intervention: Home oxygen therapy
Number of subjects: 92
Study 16510641 — intervention group
Group type: COMPARATOR
Intervention: Inpatient admission
Number of subjects: 92
Study 15213587 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based pharmacotherapy algorithm
Number of subjects: 64
Study 15213587 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 64
Study 11360134 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium and zinc supplementation (Se 200 microg/day and Zn 21 mg/day) for 50 days
Number of subjects: 60
Study 11360134 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 60
Study 9340698 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (30 mg daily)
Number of subjects: 30
Study 8369892 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercises
Number of subjects: 47
Study 8369892 — intervention group
Group type: COMPARATOR
Intervention: Hydrotherapy (twice weekly for 6 weeks in addition to home exercises)
Number of subjects: 47
Study 8369892 — intervention group
Group type: COMPARATOR
Intervention: Hydrotherapy
Number of subjects: 47
Study 3789649 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (20-50 mg/day)
Number of subjects: 24
Study 3789649 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacrinone (50-100 mg/day)
Number of subjects: 24
Study 3789649 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacrinone plus amiloride (50-100 mg and 5-10 mg/day)
Number of subjects: 24
Study 3789649 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during 4-week run-in period)
Number of subjects: 24
Study 30103772 — intervention group
Group type: EXPERIMENTAL
Intervention: C21 (an angiotensin type 2 receptor agonist)
Number of subjects: 0
Study 30103772 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (an angiotensin receptor blocker)
Number of subjects: 0
Study 30103772 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline/C21 followed by Candesartan
Number of subjects: 0
Study 30103772 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline/C21 monotherapy
Number of subjects: 0
Study 29354973 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-separated moxibustion at Baliao points combined with Bushen Huoxue formula
Number of subjects: 50
Study 29354973 — intervention group
Group type: COMPARATOR
Intervention: Bushen Huoxue formula alone
Number of subjects: 50
Study 26259675 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncoated mini-tablets
Number of subjects: 151
Study 26259675 — intervention group
Group type: COMPARATOR
Intervention: Syrup
Number of subjects: 151
Study 26259675 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 151
Study 23103075 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation period of 5 weeks (Group 1)
Number of subjects: 18
Study 23103075 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation period of 14 weeks (Group 2)
Number of subjects: 18
Study 21147783 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium (0.3 mg kg⁻¹)
Number of subjects: 75
Study 21147783 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (20 µg kg⁻¹)
Number of subjects: 75
Study 21147783 — intervention group
Group type: COMPARATOR
Intervention: Placebo (i.v. saline 0.5 ml kg⁻¹)
Number of subjects: 75
Study 18509206 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin
Number of subjects: 12
Study 18509206 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg rosuvastatin
Number of subjects: 12
Study 18509206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17196051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 575
Study 17196051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 575
Study 17196051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study 17196051 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine vs. Placebo
Number of subjects: 575
Study 17196051 — intervention group
Group type: COMPARATOR
Intervention: Lithium vs. Placebo
Number of subjects: 575
Study 17196051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine vs. Lithium
Number of subjects: 575
Study 15018018 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 50 microg/g ointment
Number of subjects: 41
Study 15018018 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol 50 microg/g cream
Number of subjects: 41
Study 11115258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 581
Study 9402292 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% (w/v) HSA
Number of subjects: 413
Study 9402292 — intervention group
Group type: COMPARATOR
Intervention: 8% (v/v) FCoS
Number of subjects: 413
Study 8219654 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment; hemoglobin A1c before: 11.3 +/- 2.8, after: 7.0 +/- 1.0
Number of subjects: 0
Study 8219654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea treatment; hemoglobin A1c before: 11.3 +/- 1.4, after: 7.3 +/- 0.9
Number of subjects: 0
Study 8219654 — intervention group
Group type: COMPARATOR
Intervention: Control group; carnitine levels did not differ from control group and did not change significantly during the observed period.
Number of subjects: 0
Study 2442322 — intervention group
Group type: EXPERIMENTAL
Intervention: COPA (cyclophosphamide, vincristine, prednisone, and doxorubicin)
Number of subjects: 332
Study 2442322 — intervention group
Group type: EXPERIMENTAL
Intervention: COPA + Bleo (cyclophosphamide, doxorubicin, prednisone, vincristine, and bleomycin)
Number of subjects: 332
Study 2442322 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP-BOP (cyclophosphamide, doxorubicin, procarbazine, bleomycin, vincristine, and prednisone)
Number of subjects: 332
Study 2442322 — intervention group
Group type: COMPARATOR
Intervention: COPA
Number of subjects: 332
Study 2442322 — intervention group
Group type: EXPERIMENTAL
Intervention: COPA + Bleo
Number of subjects: 332
Study 2442322 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP-BOP
Number of subjects: 332
Study 31729108 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnolol additive (MA) at 100, 200, and 300 mg/kg for 3 weeks
Number of subjects: 275
Study 31729108 — intervention group
Group type: COMPARATOR
Intervention: Colistin sulphate (CS) at 30 mg/kg for 3 weeks
Number of subjects: 275
Study 29898827 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 666
Study 29898827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 666
Study 28379873 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered positive psychology program
Number of subjects: 276
Study 28379873 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive-behavioral program
Number of subjects: 276
Study 28379873 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 276
Study 26246481 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive follow-up including physical examination, bone scintigraphy, chest CT, abdominal CT, brain MRI/CT, and frequent tumor marker evaluations.
Number of subjects: 1700
Study 26246481 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up including physical examination at the same frequency and tumor markers evaluated once a year.
Number of subjects: 1700
Study 23908141 — intervention group
Group type: EXPERIMENTAL
Intervention: MCPH1-2550-CC genotype with 10-27 pack-years of smoking
Number of subjects: 1348
Study 23908141 — intervention group
Group type: EXPERIMENTAL
Intervention: MCPH1-2550-TC genotype with >27 pack-years of smoking
Number of subjects: 1348
Study 23908141 — intervention group
Group type: EXPERIMENTAL
Intervention: TopBP1-3257 A allele in current smokers
Number of subjects: 1348
Study 21918956 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (two cycles of cisplatin and 5-fluorouracil)
Number of subjects: 330
Study 21918956 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chemotherapy (two cycles of cisplatin and 5-fluorouracil)
Number of subjects: 330
Study 19322976 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 0
Study 19322976 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 0
Study 19322976 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous intervention (PCI) for ST
Number of subjects: 0
Study 16700031 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendon vibration applied to the wrist extensor muscles
Number of subjects: 3
Study 14570671 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone tracheal tube
Number of subjects: 80
Study 12598249 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 0
Study 12598249 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0
Study 10507591 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous antihistamines (diphenhydramine, 1 mg/kg, and cimetidine, 4 mg/kg)
Number of subjects: 40
Study 10507591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8942464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 46
Study 8942464 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 46
Study 1925417 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone
Number of subjects: 41
Study 1925417 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 41
Study 6642386 — intervention group
Group type: EXPERIMENTAL
Intervention: Alizapride
Number of subjects: 40
Study 6642386 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 40
Study 4028748 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg/kg of dipyridamole for 24 hours
Number of subjects: 40
Study 4028748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 4028748 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups received 100 mg of aspirin daily
Number of subjects: 40
Study 30044302 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI (efavirenz or nevirapine)
Number of subjects: 400
Study 30044302 — intervention group
Group type: COMPARATOR
Intervention: PI (lopinavir/ritonavir)
Number of subjects: 400
Study 30044302 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI
Number of subjects: 400
Study 30044302 — intervention group
Group type: COMPARATOR
Intervention: PI
Number of subjects: 400
Study 28176386 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive bisphosphonate therapy (zoledronic acid)
Number of subjects: 502
Study 28176386 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 502
Study 26262251 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly specific reminders (to monitor K+) and alerts (of hyperkalaemia)
Number of subjects: 0
Study 26262251 — intervention group
Group type: COMPARATOR
Intervention: Reminders and alerts suppressed
Number of subjects: 0
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status measured by Mini Nutritional Assessment (MNA)
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of dementia
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced age and worse cognitive, functional and behavioural profile
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural symptoms (NPI-Q)
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Dependence in any basic or instrumental ADL
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding dependence
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Food preparation dependence
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model for at risk/malnutrition
Number of subjects: 940
Study 23538648 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model for malnutrition
Number of subjects: 940
Study 21147262 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (6 g/day for ≥1 month)
Number of subjects: 61
Study 18279500 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-point scale version of the Norwegian Function Assessment Scale (NFAS)
Number of subjects: 0
Study 18279500 — intervention group
Group type: COMPARATOR
Intervention: Four-point scale version of the Norwegian Function Assessment Scale (NFAS)
Number of subjects: 0
Study 16545510 — intervention group
Group type: EXPERIMENTAL
Intervention: PCECV
Number of subjects: 180
Study 16545510 — intervention group
Group type: EXPERIMENTAL
Intervention: PVRV
Number of subjects: 180
Study 16545510 — intervention group
Group type: COMPARATOR
Intervention: PCECV or PVRV
Number of subjects: 180
Study 12601676 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose administration of Hypericum extract LI 160 (6 or 12 coated tablets, 5400 or 10800 microgram hypericin)
Number of subjects: 72
Study 12601676 — intervention group
Group type: EXPERIMENTAL
Intervention: Steady-state administration of Hypericum extract LI 160 (initial dose of 6 tablets, 5400 microgram hypericin, followed by 3 x 1 tablets, 2700 microgram hypericin per day for 7 days)
Number of subjects: 72
Study 10831141 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents responding quickly to scenarios
Number of subjects: 55
Study 10831141 — intervention group
Group type: COMPARATOR
Intervention: Mothers interpreting scenarios
Number of subjects: 55
Study 9122747 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) followed by autologous bone marrow transplantation
Number of subjects: 200
Study 9122747 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 200
Study 8447211 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesophageal rewarmer (OeR group)
Number of subjects: 20
Study 8447211 — intervention group
Group type: COMPARATOR
Intervention: Control group (without oesophageal rewarmer)
Number of subjects: 20
Study 3462423 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Ambulatory Peritoneal Dialysis (CAPD)
Number of subjects: 76
Study 3462423 — intervention group
Group type: COMPARATOR
Intervention: Chronic Hemodialysis
Number of subjects: 76
Study 29940536 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based techniques
Number of subjects: 151
Study 29940536 — intervention group
Group type: COMPARATOR
Intervention: Control-based techniques
Number of subjects: 151
Study 29940536 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 151
Study 26313157 — intervention group
Group type: EXPERIMENTAL
Intervention: MNTX-ER (500 mg)
Number of subjects: 15
Study 26313157 — intervention group
Group type: COMPARATOR
Intervention: MNTX-SC (12 mg)
Number of subjects: 15
Study 26313157 — intervention group
Group type: COMPARATOR
Intervention: MNTX-IR (500 mg)
Number of subjects: 15
Study 24980265 — intervention group
Group type: EXPERIMENTAL
Intervention: Live saxophone music therapy (30 minutes)
Number of subjects: 114
Study 24980265 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 114
Study 22633316 — intervention group
Group type: COMPARATOR
Intervention: Posturographic parameters (static and dynamic tests)
Number of subjects: 89
Study 22633316 — intervention group
Group type: COMPARATOR
Intervention: Limits of stability test
Number of subjects: 89
Study 22633316 — intervention group
Group type: COMPARATOR
Intervention: Rhythmic weight shift tests
Number of subjects: 89
Study 19789440 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous lateral rotation therapy
Number of subjects: 0
Study 19789440 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 0
Study 17999977 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir (49 on 400 mg once daily, and 53 on 300 mg plus 100 mg of ritonavir once daily)
Number of subjects: 189
Study 17999977 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir
Number of subjects: 189
Study 16642175 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal integration of local motion direction signals in amblyopia
Number of subjects: 0
Study 16642175 — intervention group
Group type: COMPARATOR
Intervention: Previous studies on global motion processing
Number of subjects: 0
Study 16642175 — intervention group
Group type: COMPARATOR
Intervention: Previous studies on signal integration
Number of subjects: 0
Study 14662267 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy with the X-SIZER device
Number of subjects: 797
Study 14662267 — intervention group
Group type: COMPARATOR
Intervention: Control (no thrombectomy)
Number of subjects: 797
Study 10716102 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine only (5 days)
Number of subjects: 98
Study 10716102 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine, oxazepam, baclofen, and ketoprofene with naloxone and naltrexone (2 days)
Number of subjects: 98
Study 10716102 — intervention group
Group type: COMPARATOR
Intervention: Methadone in decreasing doses (10 days)
Number of subjects: 98
Study 9213861 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg/12 hourly)
Number of subjects: 20
Study 9213861 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms/12 hourly)
Number of subjects: 20
Study 1528502 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 0
Study 1528502 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 2996747 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemo‐radio‐immunotherapy regimen with cyclophosphamide, doxorubicin, vincristine, VP‐16, and cisplatin, followed by prophylactic whole‐brain radiotherapy and multifield radiotherapy.
Number of subjects: 35
Study 2996747 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymosin, fraction V (experimental group).
Number of subjects: 35
Study 2996747 — intervention group
Group type: COMPARATOR
Intervention: No thymosin (control group).
Number of subjects: 35
Study 31605550 — intervention group
Group type: EXPERIMENTAL
Intervention: M. bovoculi vaccine (2 doses)
Number of subjects: 370
Study 31605550 — intervention group
Group type: COMPARATOR
Intervention: Control (unvaccinated)
Number of subjects: 370
Study 29411765 — intervention group
Group type: EXPERIMENTAL
Intervention: aceclofenac + pregabalin
Number of subjects: 60
Study 29411765 — intervention group
Group type: COMPARATOR
Intervention: aceclofenac
Number of subjects: 60
Study 25719429 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine hydrochloride (1500 mg/d) plus chondroitin sulfate (1200 mg/d) for 28 days
Number of subjects: 18
Study 25719429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 23011351 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 41
Study 23011351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41